Artenimol: all 91 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Dihydroartemisinin for MAFLDRecruitingNCT07679542Phase 1/2
- A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus ErythematosusNot yet recruitingNCT07557927Phase 2
- Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium VivaxNot yet recruitingNCT07533136Not applicable
- Perennial Malaria Chemoprevention in the Malaria Vaccine EraNot yet recruitingNCT07322068Phase 4
- Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community TransmissionNot yet recruitingNCT07246525Phase 4
- Focal Mass Drug Administration for the Prevention of Malaria in PregnancyRecruitingNCT07021430Early Phase 1
- Efficacy of Dihydroartemisinin for Treating Acne VulgarisRecruitingNCT07007078Early Phase 1
- Safety of Antimalarials in the FIRst trimEsterRecruitingNCT06962319Phase 3
- Dihydroartemisinin for the Treatment of Polycystic Ovary SyndromeRecruitingNCT06842524Phase 2
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingNCT05946642Phase 3
- Dihydroartemisinin-Piperaquine in the Context of Antiretroviral TherapyCompletedNCT04487145Phase 4Results posted
- Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in UgandaCompletedNCT04336189Phase 3Results posted
- Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)CompletedNCT03178643Phase 4Results posted
- Chemopreventive Therapy for Malaria in Ugandan ChildrenCompletedNCT00948896Phase 3Results posted
- Intermittent Preventive Treatment of Malaria in SchoolchildrenCompletedNCT00852371Phase 3Results posted
- CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal CancerActive, not recruitingNCT07801352Phase 2
- IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe FloodingActive, not recruitingNCT06870344Not applicable
- Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaActive, not recruitingNCT06516042Phase 3
- Efficacy of Dihydroartemisinin for Treating PCOSCompletedNCT06417099Phase 2
- The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination TherapyCompletedNCT06347471Phase 4
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, MalawiCompletedNCT06083688Phase 4
- Comparing Chemoprevention Drugs for School-based Malaria ControlCompletedNCT05980156Phase 4
- Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in TanzaniaCompletedNCT05874869Not applicable
- Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba RegencyCompletedNCT05829187Phase 2
- The Effect of Dihydroartemisinin in PCOSCompletedNCT05465135Phase 4
- Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyActive, not recruitingNCT05426434Phase 3
- In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in MozambiqueCompletedNCT05343312Phase 4
- Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, UgandaActive, not recruitingNCT05323721Phase 4
- Comparing Chemoprevention Approaches for School-based Malaria ControlCompletedNCT05244954Phase 4
- Therapeutic Efficacy Study of AL and DP in Western KenyaCompletedNCT05060198Not applicable
- Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)Active, not recruitingNCT04978272Phase 3
- Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating MalariaCompletedNCT04897919Phase 4
- Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination ActivitiesCompletedNCT04864444Not applicable
- Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell AnaemiaCompletedNCT04844099Phase 3
- Boosting the Impact of SMC Through Simultaneous Screening and Treatment of RoommatesCompletedNCT04816461Phase 4
- Malaria Therapeutic Efficacy Study, RwandaCompletedNCT04767217Phase 4
- Malaria Therapeutic Efficacy Study (TES) KenyaCompletedNCT04767191Phase 4
- Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaCompletedNCT04245033Phase 4
- Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)CompletedNCT04158713Phase 3
- Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of AntimalarialsActive, not recruitingNCT04009343Phase 2/3
- Improving Maternal heAlth by Reducing Malaria in African HIV WomenCompletedNCT03671109Phase 3
- Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in TanzaniaCompletedNCT03640403Phase 3
- Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria EliminationCompletedNCT03576313Phase 3
- Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland TanzaniaCompletedNCT03431714Phase 4
- Exploratory Study of DHA in Systemic Lupus Erythematosus PatientsStatus unknownNCT03396393Phase 2
- Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in AfricaCompletedNCT03208179Phase 3
- Efficacy and Safety of IPTp-DP Versus IPTp-SP in MalawiCompletedNCT03009526Phase 3
- Evaluation of Community-based Mass Screening and Treatment for Malaria in Western KenyaCompletedNCT02987270Phase 3
- Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara AfricaCompletedNCT02974348Phase 3
- Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the CongoCompletedNCT02940756Phase 4
- Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern MozambiqueCompletedNCT02914145Not applicable
- RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria TransmissionCompletedNCT02878200Not applicable
- Post-discharge Malaria Chemoprevention(PMC) StudyCompletedNCT02671175Phase 3
- Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The GambiaTerminatedNCT02654730Phase 2/3
- Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment CampaignsCompletedNCT02605720Phase 3
- In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment FailureCompletedNCT02590627Phase 4
- Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, IndonesiaCompletedNCT02325180Phase 4
- Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in SwazilandCompletedNCT02315690Phase 3
- Comparison of the ECG Effects Related to Pharmacokinetic Profile of Chloroquine and PiperaquineCompletedNCT02192944Phase 4
- A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine TetraphosphateCompletedNCT02184637Phase 1
- Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax MalariaTerminatedNCT02110784Phase 2
- School-Based Treatment With ACT to Reduce TransmissionCompletedNCT02009215Phase 4
- Malaria in Early Life StudyCompletedNCT02001428Not applicable
- Evaluation of the Efficacy of Artemisinin Combination Therapy in KenyaStatus unknownNCT01899820Phase 3
- Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in VietnamCompletedNCT01887821Phase 4
- Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus PrimaquineCompletedNCT01878357Phase 4
- Targeted Chemo-elimination (TCE) of MalariaCompletedNCT01872702Not applicable
- Artemisinin-Based Antimalarial Combinations and Clinical Response in CameroonCompletedNCT01845701Phase 3
- Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi NigerCompletedNCT01755559Phase 4
- Improving Anti-malarial Treatment Options in Guinea-Bissau - Part ACompletedNCT01704508Phase 4
- Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in KenyaCompletedNCT01669941Phase 4
- Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in GhanaCompletedNCT01651416Phase 4
- Compare the Effectiveness Between Existing Treatment and New TreatmentTerminatedNCT01640587Not applicable
- Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)CompletedNCT01640574Phase 3
- Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum CasesCompletedNCT01392014Phase 4
- Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in MalawiCompletedNCT01326754Not applicable
- Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax MalariaCompletedNCT01288820Phase 3
- Malaria Active Epidemiology and Treatment StudyCompletedNCT01280162Not applicable
- Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in GhanaCompletedNCT01231113Phase 3
- Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult VolunteersCompletedNCT01222962Phase 1
- A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™CompletedNCT01222949Phase 1
- Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy VolunteersCompletedNCT01103830Phase 1
- Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in ChildrenCompletedNCT01082705Phase 3
- Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in PregnancyCompletedNCT01054248Phase 3
- Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)CompletedNCT00868465Not applicable
- Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With MalariaCompletedNCT00852423Phase 3
- Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina FasoCompletedNCT00845533Phase 4
- A Comparative Study of Artekin With Standard Malarial Treatment Regimes in AfghanistanCompletedNCT00682578Phase 3
- Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in SenegalCompletedNCT00529620Phase 3
- Interactions Between HIV and Malaria in African ChildrenCompletedNCT00527800Phase 3
- Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in PeruCompletedNCT00373607Phase 3